DANIEL D WASHBURN

Allopathic & Osteopathic Physicians|Internal Medicine ENID, OK NPI 1013901461

General Payments — all program years on this page

$1,557.26

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 87
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $13.95 across 1 record · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $13.951

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Novo Nordisk AS $13.951

By program year

Program yearAmountRecords
2018 $434.7222
2019 $187.7214
2020 $217.4016
2021 $299.0816
2022 $296.3013
2023 $108.095
2024 $13.951

Records — PY2024 (1)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096765178 Novo Nordisk Inc $13.95 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.